These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1352 related articles for article (PubMed ID: 26597426)

  • 21. Natural brominated phenoxyphenols kill persistent and biofilm-incorporated cells of MRSA and other pathogenic bacteria.
    van Geelen L; Kaschani F; Sazzadeh SS; Adeniyi ET; Meier D; Proksch P; Pfeffer K; Kaiser M; Ioerger TR; Kalscheuer R
    Appl Microbiol Biotechnol; 2020 Jul; 104(13):5985-5998. PubMed ID: 32418125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
    Viganor L; Howe O; McCarron P; McCann M; Devereux M
    Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections.
    Lebeaux D; Leflon-Guibout V; Ghigo JM; Beloin C
    J Antimicrob Chemother; 2015; 70(6):1704-12. PubMed ID: 25712314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria.
    Hall CW; Mah TF
    FEMS Microbiol Rev; 2017 May; 41(3):276-301. PubMed ID: 28369412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria.
    Starr CG; Ghimire J; Guha S; Hoffmann JP; Wang Y; Sun L; Landreneau BN; Kolansky ZD; Kilanowski-Doroh IM; Sammarco MC; Morici LA; Wimley WC
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8437-8448. PubMed ID: 32241895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities.
    Penesyan A; Gillings M; Paulsen IT
    Molecules; 2015 Mar; 20(4):5286-98. PubMed ID: 25812150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural antimicrobial peptide complexes in the fighting of antibiotic resistant biofilms: Calliphora vicina medicinal maggots.
    Gordya N; Yakovlev A; Kruglikova A; Tulin D; Potolitsina E; Suborova T; Bordo D; Rosano C; Chernysh S
    PLoS One; 2017; 12(3):e0173559. PubMed ID: 28278280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential application of antimicrobial peptides in the treatment of bacterial biofilm infections.
    Strempel N; Strehmel J; Overhage J
    Curr Pharm Des; 2015; 21(1):67-84. PubMed ID: 25189860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond antibiotics: CRISPR/Cas9 triumph over biofilm-associated antibiotic resistance infections.
    Zuberi A; Ahmad N; Ahmad H; Saeed M; Ahmad I
    Front Cell Infect Microbiol; 2024; 14():1408569. PubMed ID: 39035353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections.
    Mansour SC; de la Fuente-Núñez C; Hancock RE
    J Pept Sci; 2015 May; 21(5):323-9. PubMed ID: 25358509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
    Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
    Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Strategies to Combat Bacterial Biofilms.
    Hemmati F; Rezaee MA; Ebrahimzadeh S; Yousefi L; Nouri R; Kafil HS; Gholizadeh P
    Mol Biotechnol; 2021 Jul; 63(7):569-586. PubMed ID: 33914260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial resistance in biofilm-associated bacteria.
    Venkatesan N; Perumal G; Doble M
    Future Microbiol; 2015; 10(11):1743-50. PubMed ID: 26517598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate.
    Mohamed MF; Brezden A; Mohammad H; Chmielewski J; Seleem MN
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):848-859. PubMed ID: 28132897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiofilm Peptides: Potential as Broad-Spectrum Agents.
    Pletzer D; Hancock RE
    J Bacteriol; 2016 Oct; 198(19):2572-8. PubMed ID: 27068589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-biofilm peptides as a new weapon in antimicrobial warfare.
    Pletzer D; Coleman SR; Hancock RE
    Curr Opin Microbiol; 2016 Oct; 33():35-40. PubMed ID: 27318321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protocols for Studying Inhibition and Eradication of Bacterial Biofilms by Antimicrobial Peptides.
    Sarojini V
    Methods Mol Biol; 2017; 1548():323-330. PubMed ID: 28013515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including Biofilms.
    Borges A; Abreu AC; Dias C; Saavedra MJ; Borges F; Simões M
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.